Cancer-Killing virus tested in humans for first time
NCT ID NCT06171178
Summary
This was the first study in people to test a new cancer treatment called ASP1012, which is a virus modified in a lab to specifically infect and destroy cancer cells. The main goals were to find a safe dose and check for side effects in adults whose cancer had spread and who had run out of standard treatment options. The study was terminated early and did not proceed to later phases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory Winship Cancer Institute
Atlanta, Georgia, 30322, United States
-
Gabrail Cancer and Research Center
Canton, Ohio, 44718, United States
-
Hoag Memorial Hospital Presbyterian
Newport Beach, California, 92663, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Mary Crowley Cancer Research
Dallas, Texas, 75230, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
The Angeles Clinic and Research Institute
Los Angeles, California, 90025, United States
-
University of Iowa Hospitals
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.